Journal article

Programmed cell death-1 inhibition in lymphoma

Eliza A Hawkes, Andrew Grigg, Geoff Chong

The Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2015

DOI: 10.1016/S1470-2045(15)70103-8

Grants

Funding Acknowledgements

EAH receives funding from the North Eastern Metropolitan Integrated Cancer Services. AG declares no competing interests. GC receives funding from Amgen, Novartis, and Astellas.

Citation metrics

37Web of Science
44Scopus

Keywords

Tumor Microenvironment
Life Sciences & Biomedicine
Antibodies, Monoclonal
Programmed Cell Death 1 Receptor
Science & Technology
Pd-1 Expression
Cd4(+) T-Cells
Follicular Lymphoma
Clinical Trials As Topic
Clinical-Significance
Hodgkin-Lymphoma
Prognostic-Factors
Ligands
Oncology
Ligand 1
Molecular Targeted Therapy
Lymphoma
Anti-Pd-1 Antibody
Humans
Signal Transduction
Lymphoproliferative Disorders